Vortioxetine Hydrobromide
Cat.No:IV0810 Solarbio
CAS:960203-27-4
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Neuronal Signal Pathway >
Vortioxetine HydrobromideCAS:960203-27-4
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
CAS | 960203-27-4 |
Name | Vortioxetine Hydrobromide |
Molecular Formula | C18H23BrN2S |
Molecular Weight | 379.36 |
Solubility | Soluble in DMSO(Need ultrasonic) |
Purity | ≥98% |
Appearance | Light yellow to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00003305 |
SMILES | CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br |
InChIKey | VNGRUFUIHGGOOM-UHFFFAOYSA-N |
InChI | InChI=1S/C18H22N2S.BrH/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20;/h3-8,13,19H,9-12H2,1-2H3;1H |
PubChem CID | 56843850 |
Target Point | 5-HT Receptor;Serotonin Transporter |
Passage | Neuronal Signaling;GPCR & G Protein |
Background | It is an inhibitor of the 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and the serotonin transporter (SERT). |
Biological Activity | Vortioxetine Hydrobromide 是 5-HT1A,5-HT1B,5-HT3A,5-HT7 受体 和5-羟色胺转运体 (SERT) 的抑制剂,其Ki值分别为 15 nM,33 nM,3.7 nM,19 nM 和 1.6 nM。[1] |
In Vitro | Vortioxetine hydrobromide is a novel multimodal serotonergic compound,displaying high affinity for recombinant human 5-HT(1A)(K(i)= 15 nM),5-HT(1B)(K(i)= 33 nM),5-HT(3A)(K(i)= 3.7 nM),5-HT(7)(K(i)= 19 nM),and noradrenergic β(1)(K(i)= 46 nM)receptors,and SERT(K(i)= 1.6 nM). [1] |
In Vivo | In conscious rats,Vortioxetine hydrobromide significantly increased extracellular 5-HT levels in the brain after acute and 3 days of treatment. Following the 3-day treatment(5 or 10(mg/kg)/day)SERT occupancies were only 43% and 57%,respectively. [1]Acute and repeated dosing of vortioxetine(5 or 10(mg/kg)/day)produced more pronounced anxiolytic- and antidepressant-like activities than fluoxetine.[2]Vortioxetine(10mg/day)did not impair driving,cognitive,or psychomotor performance after single or multiple doses.[3]Vortioxetine 5mg did not improve symptoms of generalized anxiety disorder(GAD; HAM-A total score ≥20 and MADRS score ≤16) over 8 weeks of treatment.[4]Vortioxetine has antidepressant- and anxiolytic-like effects in the rat forced swim(Flinders Sensitive Line)and social interaction and conditioned fear tests(minimal effective doses: 7.8,2.0,and 3.9 mg/kg). [5] |
Animal Experiment | Vortioxetine was assessed in BalB/cJ@RJ mice using the open-field and forced-swim tests(acute: p.o. 1 h,repeated: daily p.o. 21 days),and in 129S6/SvEvTac mice using the novelty suppressed feeding paradigm(acute: p.o. 1 h,sustained: daily p.o. 14 or 21 days). Fluoxetine and diazepam were controls. [2] |
Data Literature Source | [1]. Bang-Andersen B,et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem. 2011 May 12;54(9):3206-21. [2]. Guilloux JP,et al. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 2013 Oct;73:147-59. [3]. Theunissen EL,et al. A randomized trial on the acute and steady-state effects of a new antidepressant,vortioxetine (Lu AA21004),on actual driving and cognition. Clin Pharmacol Ther. 2013 Jun;93(6):493-501. [4]. Rothschild AJ,et al. Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized,double-blind,placebo-controlled clinical trial in the United States. Eur Neuropsychopharmacol. 2012 Dec;22(12):858-66. [5]. M rk A,et al. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther. 2012 Mar;340(3):666-75. |
Unit | Bottle |
Specification | 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.